MHC-I INTRATUMOR HETEROGENEITY DETERMINES ONCOGENIC AND METASTATIC CAPACITY, AND IMMUNE RESPONSE

被引：0
|
作者：
Romero-Garcia, Irene [1 ]
Linares, Isabel [1 ]
Algarra, Ignacio [2 ]
Collado, Antonia [3 ]
Garrido, Federico [1 ]
Garcia-Lora, Angel [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, UGC Lab Clin, Granada, Spain
[2] Univ Jaen, Dept Ciencias Salud, Jaen, Spain
[3] Hosp Univ Virgen de las Nieves, Unidad Invest, Granada, Spain
来源：
TISSUE ANTIGENS | 2014年 / 84卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [21] Activated SUMOylation suppresses the MHC-I Antigen Presentation and Immune Cell Function and blocks the tumor-specific Immune Response
    Demel, U.
    Boeger, M.
    Yousefian, S.
    Grunert, C.
    Zhang, L.
    Hotz, P.
    Gottschlich, A.
    Kobold, S.
    Busse, A.
    Haas, S.
    Muller, S.
    Wirth, M.
    Schick, M.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 260 - 260
  • [22] PRC2-mediated MHC-I silencing drives immune evasion
    Bradley, Conor A.
    NATURE REVIEWS CANCER, 2019, 19 (12) : 664 - 664
  • [23] MHC-I genotype and tumor mutational burden predict response to immunotherapy
    Goodman, Aaron M.
    Castro, Andrea
    Pyke, Rachel Marty
    Okamura, Ryosuke
    Kato, Shumei
    Riviere, Paul
    Frampton, Garrett
    Sokol, Ethan
    Zhang, Xinlian
    Ball, Edward D.
    Carter, Hannah
    Kurzrock, Razelle
    GENOME MEDICINE, 2020, 12 (01)
  • [24] MHC-I genotype and tumor mutational burden predict response to immunotherapy
    Aaron M. Goodman
    Andrea Castro
    Rachel Marty Pyke
    Ryosuke Okamura
    Shumei Kato
    Paul Riviere
    Garrett Frampton
    Ethan Sokol
    Xinlian Zhang
    Edward D. Ball
    Hannah Carter
    Razelle Kurzrock
    Genome Medicine, 12
  • [25] Implications of Heterogeneity in Breast Tumor Cell MHC-I Expression on Immunity and Therapeutic Resistance
    Taylor, Brandie C.
    Sun, Xiaopeng
    Balko, Justin
    Gonzalez-Ericsson, Paula
    Sanders, Melinda
    CANCER RESEARCH, 2023, 83 (05)
  • [26] A membrane-associated MHC-I inhibitory axis for cancer immune evasion
    Chen, Xufeng
    Lu, Qiao
    Zhou, Hua
    Liu, Jia
    Nadorp, Bettina
    Lasry, Audrey
    Sun, Zhengxi
    Lai, Baoling
    Rona, Gergely
    Zhang, Jiangyan
    Cammer, Michael
    Wang, Kun
    Al-Santli, Wafa
    Ciantra, Zoe
    Guo, Qianjin
    You, Jia
    Sengupta, Debrup
    Boukhris, Ahmad
    Zhang, Hongbing
    Liu, Cheng
    Cresswell, Peter
    Dahia, Patricia L. M.
    Pagano, Michele
    Aifantis, Iannis
    Wang, Jun
    CELL, 2023, 186 (18) : 3903 - 3920.e21
  • [27] Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade.
    Gu, Shengqing
    Zhang, Wubing
    Wang, Xiaoqing
    Jiang, Peng
    Traugh, Nicole
    Li, Ziyi
    Meyer, Clifford
    Stewig, Blair
    Xie, Yingtian
    Bu, Xia
    Manos, Michael
    Font-Tello, Alba
    Gjini, Evisa
    Lako, Ana
    Lim, Klothilda
    Conway, Jake
    Tewari, Alok
    Zeng, Zexian
    Das Sahu, Avinash
    Tokheim, Collin
    Weirather, Jason L.
    Fu, Jingxin
    Zhang, Yi
    Kroger, Benjamin
    Liang, Jin Hua
    Cejas, Paloma
    Freeman, Gordon J.
    Rodig, Scott J.
    Long, Henry
    Gewurz, Benjamin E.
    Hodi, F. Stephen
    Brown, Myles
    Liu, X. Shirley
    CANCER RESEARCH, 2021, 81 (13)
  • [28] FASN inhibition overcomes immune evasion by upregulating MHC-I in hepatocellular carcinoma
    Huang, Jiao
    Tsang, Wai Ying
    Fang, Xiaona
    Zhang, Yu
    Luo, Jie
    Gong, Lanqi
    Zhang, Baifeng
    Wong, Ching Ngar
    Liu, Beilei
    Huang, Jinlin
    Yang, Yuma
    Liu, Shan
    Li, Zhihong
    Guan, Xinyuan
    CANCER RESEARCH, 2023, 83 (07)
  • [29] PRC2-mediated MHC-I silencing drives immune evasion
    Conor A. Bradley
    Nature Reviews Cancer, 2019, 19 : 664 - 664
  • [30] Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation
    Oliveras-Ferraros, Cristina
    Cufi, Silvia
    Vazquez-Martin, Alejandro
    Menendez, Octavio J.
    Bosch-Barrera, Joaquim
    Martin-Castillo, Begona
    Joven, Jorge
    Menendez, Javier A.
    CELL CYCLE, 2012, 11 (05) : 865 - 870
12345